Literature DB >> 8415415

Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens.

N Santiago1, S Milstein, T Rivera, E Garcia, T Zaidi, H Hong, D Bucher.   

Abstract

Influenza virus antigen microspheres were prepared by a pH-dependent process using a protein-like polymer (proteinoid) made by thermal condensation of amino acids. The efficacy of these preparations to induce specific IgG responses when used as oral vaccines in rats was evaluated. A single enteric dose of M1 entrapped in proteinoid microspheres was able to induce a significant IgG response to M1 as early as 2 weeks postdosing, while rats dosed orally with the same M1 total dose (no microspheres) showed no detectable antibody response. An unencapsulated hemagglutinin and neuraminidase (HA-NA) preparation induced a moderate anti HA-NA IgG response. A single enteric dose of HA-NA spheres induced a response in 33% of the rats; this response was up to eight times higher than that observed in the rats dosed with unencapsulated antigen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415415     DOI: 10.1023/a:1018992924025

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

Authors:  S J Challacombe; D Rahman; H Jeffery; S S Davis; D T O'Hagan
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

2.  Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic.

Authors:  G MEIKLEJOHN; C H KEMPE; W G THALMAN; E H LENNETTE
Journal:  Am J Hyg       Date:  1952-01

3.  Vaccination at the portal of entry of infectious agents.

Authors:  A B Sabin
Journal:  Dev Biol Stand       Date:  1976

4.  Biodegradable microspheres: vaccine delivery system for oral immunization.

Authors:  J H Eldridge; R M Gilley; J K Staas; Z Moldoveanu; J A Meulbroek; T R Tice
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

5.  Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3.

Authors:  R Ray; B J Glaze; Z Moldoveanu; R W Compans
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

Review 6.  Secretory anti-influenza immunity.

Authors:  Y S Shvartsman; M P Zykov
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

Review 7.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

8.  Age-dependent antibody response in mice and humans following oral influenza immunization.

Authors:  R H Waldman; K C Bergmann; J Stone; S Howard; V Chiodo; A Jacknowitz; E R Waldman; R Khakoo
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

9.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

View more
  5 in total

1.  Intestinal patches for oral drug delivery.

Authors:  Zancong Shen; Samiir Mitragotri
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 3.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

Review 4.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

5.  Novel polymer-grafted starch microparticles for mucosal delivery of vaccines.

Authors:  P L Heritage; L M Loomes; J Jianxiong; M A Brook; B J Underdown; M R McDermott
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.